PTA

BioSkryb Genomics to Highlight Power of Next Generation Single-Cell Technology at AGBT 2024

Retrieved on: 
Tuesday, January 30, 2024
Research, Technology, Other Technology, Other Health, Biotechnology, General Health, Health, Science, Oncology, Other Science, Genomics, Product management, Mosaic, Workflow, B cell, DNA, Transcriptome, Single-cell analysis, ETH Zurich, CNV, Exome, PTA, SNV, Leukemia

As a Bronze Sponsor, BioSkryb will also host a workshop and networking event at the meeting.

Key Points: 
  • As a Bronze Sponsor, BioSkryb will also host a workshop and networking event at the meeting.
  • “Our industry-first next generation single-cell technology offers the most comprehensive view of the integrated genome, transcriptome, and targeted proteins from each cell in a single workflow, and we are thrilled to highlight novel applications of our platforms at AGBT,” said Suresh Pisharody, CEO, BioSkryb.
  • BioSkryb’s events at AGBT 2024 are as follows:
    Jay A.A. West, Ph.D., Co-Founder & CTO, BioSkryb Genomics advances multiomics and highly accurate single-cell analysis with the next generation of single-cell technology.
  • Join BioSkryb and AGBT attendees to mingle with genomics and multiomics thought leaders over top-shelf bourbon selections and gourmet bacon-themed appetizers.

Pediatric Cancer Foundation Welcomes Children's Advocate Sandy Ward to Advisory Board

Retrieved on: 
Wednesday, January 17, 2024
PTA, Ward, International school, Advisory board, International, Pension, Nursing

FORT MYERS, Fla., Jan. 17, 2024 /PRNewswire-PRWeb/ -- Bridge To A Cure Foundation has added Sandy Ward as its newest addition to the Bridge To A Cure Foundation Board of Advisors. Her passion for making a positive impact in the lives of children was developed through her extensive background in various corporate and community support roles and volunteer leadership.

Key Points: 
  • Bridge To A Cure Foundation has added children's advocate Sandy Ward as its newest addition to the Bridge To A Cure Foundation Board of Advisors.
  • FORT MYERS, Fla., Jan. 17, 2024 /PRNewswire-PRWeb/ -- Bridge To A Cure Foundation has added Sandy Ward as its newest addition to the Bridge To A Cure Foundation Board of Advisors.
  • "[Sandy Ward's] extensive volunteering and diverse experiences demonstrate a remarkable commitment to community, leadership, and making a positive impact for kids and families."
  • "We are thrilled to welcome Sandy Ward to the Advisory Board, confident that her wealth of experiences and passion for philanthropy will contribute significantly to the success of our mission."

How Involved are You in Your Teen’s High School Education?

Retrieved on: 
Tuesday, January 9, 2024
Primary, Secondary, Family, Education, Consumer, Teens, Parenting, Hispanic, Multimedia, Student, Museum, PTA, Learning, Parent, Exercise, Time management, History, Child, Sleep, Communication, Tutoring

What is the one thing above all others that determines how successful a student will be in high school?

Key Points: 
  • What is the one thing above all others that determines how successful a student will be in high school?
  • “High school work is harder than in middle school and there is added pressure of test scores, planning for college or trade school and the social aspects of becoming an adult,” said Lindsay Reese, area superintendent at Learn4Life.
  • Having unrealistically high expectations can have the opposite effect and the student may feel they’ll never be good enough.
  • Reese adds that it is the teamwork of teachers, tutors, school counselors and parents to create the best possible learning environment.

Ceva Extends its Connect IP Portfolio with Wi-Fi 7 Platform for High-End Consumer and Industrial IoT

Retrieved on: 
Wednesday, January 3, 2024
APS, Wi-Fi, MRU, MAC, Wireless access point, PTA, IEEE 802.11be, Wi-Fi 6, PHY, IPS, Wireless, Multi, Research, Original equipment manufacturer, Internet of things, Television, Socs, IP, Access Point (Antarctica), Face, MLO, Wi-Fi Alliance, Radio, IEEE, STA, Silicon, AP, Mobile phone

ROCKVILLE, Md., Jan. 3, 2024 /PRNewswire/ -- Ceva, Inc. (NASDAQ: Ceva), the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, today announced the general release of its next generation RivieraWaves Wi-Fi 7 IP platform, further expanding its widely-licensed portfolio of connectivity IP, targeting high-end consumer and industrial applications including gateways, TVs, set-top-boxes, streaming media devices, AR/VR headsets, personal computing and smartphones. The RivieraWaves Wi-Fi 7 IP leverages all the latest advanced features of the IEEE 802.11be standard to deliver a premium high performance, cost- and power-optimized Wi-Fi solution for integration into the next wave of Wi-Fi Access Point (AP) and Station (STA) products.

Key Points: 
  • Expanding on this leadership position, Ceva's RivieraWaves Wi-Fi 7 IP provides a unique, comprehensive 802.11be MAC and PHY solution for integration into the next generation of Wi-Fi SoC products.
  • Our RivieraWaves Wi-Fi 7 IP platform incorporates all the features of this latest-generation, wireless standard, dramatically simplifying development and time-to-market for companies looking to add Wi-Fi 7 connectivity to their products."
  • Flexible RF interface enables integration with radio circuitry from multiple Ceva partners or licensee's own radio technology.
  • The RivieraWaves Wi-Fi 7 IP platform is available now for Access Point applications, with an optimized Station implementation arriving later this year.

OrbusNeich Acquires 84% Stake in an Indonesian Distributor for Approximately US$15 Million

Retrieved on: 
Monday, November 27, 2023
World Bank, PCI, Sale, PTA, Acquisition, GDP, Bank statement, Death, Percutaneous coronary intervention, World Health Organization, Growth, Patient, OrbusNeich, Hemofiltration, Cardiac catheterization, Pharmaceutical industry

The consideration for the acquisition will be funded from the proceeds of the Group's global offering and cash generated from operations.

Key Points: 
  • The consideration for the acquisition will be funded from the proceeds of the Group's global offering and cash generated from operations.
  • PT Revass is an Indonesian company that specializes in the distribution and sale of cardiovascular intervention, neuro intervention, peripheral intervention and continuous renal replacement therapy products.
  • Its profit after tax in FY2022 amounted to IDR14.3 billion (equivalent to approximately US$920,000).
  • As of 30 June 2023, its unaudited net asset value was approximately IDR88.1 billion (equivalent to approximately US$5.7 million).

OrbusNeich Adds Drug-eluting Balloons in Product Portfolio Through Acquisition of Eucatech AG

Retrieved on: 
Thursday, November 23, 2023
Abbott Laboratories, Quality of life, PCI, Sale, PTA, CSI, Acquisition, CE, Clinical trial, PTCA, Percutaneous coronary intervention, Growth, Patient, OrbusNeich

Upon completion of the acquisition, Eucatech AG will become a wholly-owned subsidiary of the Group.

Key Points: 
  • Upon completion of the acquisition, Eucatech AG will become a wholly-owned subsidiary of the Group.
  • Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, "We are pleased to announce the acquisition of Eucatech AG, a company with two decades of experience and a shared mission with OrbusNeich.
  • We believe that this acquisition will enrich our product portfolio.
  • Therefore, the Group views this acquisition as a strategic move to reinforce its market presence and distribution network .

Brookline College Launches Physical Therapist Assistant Program in Tucson

Retrieved on: 
Thursday, December 21, 2023
Campus, Brookline College, Employment, Eagle Gate College, Multimedia, Student, PTA, Medical assistant, Occupational therapy, Physical, Provo College, Nursing, Life

TUCSON, Ariz., Dec. 21, 2023 /PRNewswire-PRWeb/ -- In 2024, Brookline College will launch a Physical Therapist Assistant (PTA) program at the Tucson campus. This unique addition to their roster of programs creates a valuable opportunity that will benefit the community and the field of physical therapy. The inaugural group of students will start the program in May of 2024 with 20 available seats. In under two years, these students can earn their PTA degree and begin fulfilling careers as Physical Therapist Assistants.

Key Points: 
  • TUCSON, Ariz., Dec. 21, 2023 /PRNewswire-PRWeb/ -- In 2024, Brookline College will launch a Physical Therapist Assistant (PTA) program at the Tucson campus.
  • "I am so pleased that we can bring the high-quality program we established in Phoenix to the southern part of the state and the Tucson community," said Jane Jackson, the Physical Therapist Assistant Program Director.
  • Now, they can also enroll in a Physical Therapist Assistant program.
  • Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Unitek Training Healthcare, Eagle Gate College, Provo College, and Brookline College.

Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)

Retrieved on: 
Monday, December 18, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, FDA, Clinical Trials, Cisplatin, Neoplasm, POC, Ototoxicity, Incidence, Hearing loss, Clinical trial, Hospital, Patient, European, Audiogram, Huber loss, Perilymph, ENT, Cancer, Hertz, Congress, Hearing, Quality of life, PTA, Pharmaceutical industry, Nursing, Audiology

The trial assesses several outcome measures, including the rate and severity of ototoxicity, the change from baseline in Pure Tone Audiometry (PTA) (dB) throughout the study and the tolerance.

Key Points: 
  • The trial assesses several outcome measures, including the rate and severity of ototoxicity, the change from baseline in Pure Tone Audiometry (PTA) (dB) throughout the study and the tolerance.
  • Géraldine Honnet, Chief Medical Officer of Sensorion, said: “I’m pleased with the progress in Sensorion’s POC Phase 2a clinical study of SENS-401 in the prevention of Cisplatin-Induced Ototoxicity.
  • SENS-401 is also progressing in a second ongoing Phase 2a clinical study in the prevention of residual hearing loss following cochlear implantation.
  • Sensorion is anticipating the end of patient recruitment early 2024 and the publication of POC Phase 2a clinical primary endpoint readout in H1 2024.

FHU Physical Therapist Assistant Program Receives Accreditation Status, Set to Graduate Inaugural Cohort

Retrieved on: 
Tuesday, December 5, 2023
Freed–Hardeman University, Suite, Education, Prentice, Telephone, Love, Accreditation, Student, Multimedia, Faculty, FHU, Council, Commission, University, Curriculum, NPTE, CAPTE, Knowledge, PTA, Nursing, Physical

HENDERSON, Tenn., Dec. 5, 2023 /PRNewswire-PRWeb/ -- The Commission on Accreditation in Physical Therapy Education (CAPTE) has granted Freed-Hardeman University's Physical Therapist Assistant program accreditation status effective October 31, 2023, as reported by Dr. C.J. Vires, FHU provost and vice president for academics. This is the maximum accreditation granted by CAPTE, for a period of five years until the next reassessment period.

Key Points: 
  • The Commission on Accreditation in Physical Therapy Education (CAPTE) has granted Freed-Hardeman University's Physical Therapist Assistant program accreditation status effective October 31, 2023.
  • HENDERSON, Tenn., Dec. 5, 2023 /PRNewswire-PRWeb/ -- The Commission on Accreditation in Physical Therapy Education (CAPTE) has granted Freed-Hardeman University's Physical Therapist Assistant program accreditation status effective October 31, 2023, as reported by Dr. C.J.
  • The inaugural cohort of the PTA program began courses in the fall of 2022 and will graduate on December 15, 2023.
  • It includes 640 hours of clinical experience in both the outpatient and inpatient settings under the supervision of a licensed physical therapist or a physical therapist assistant who is supervised by a licensed physical therapist.

National PTA Names Center for Family Engagement Principal Fellows and Grant Recipients

Retrieved on: 
Tuesday, November 28, 2023
National standards, CAE, Research, Language, Learning, Disability, Student, PTAS, Child, School, Family, Knowledge, PTA, Education, Nursing, Tutoring, Management

Eight PTAs from across the country have also been selected to receive a grant from the Center for Family Engagement of $2,000 each.

Key Points: 
  • Eight PTAs from across the country have also been selected to receive a grant from the Center for Family Engagement of $2,000 each.
  • The fellowship and grant funding are made possible with support from PTA Proud National Sponsor GoGuardian.
  • The National PTA Principal Fellows for Family-School Partnerships are:
    Dr. Latonya Cooper is the principal of Sea Castle Elementary School in Miramar, Fla. Dr. Cooper has over 23 years of experience in education.
  • The 2023-2024 Advancing Family-School Partnerships Challenge grant recipients are:
    With the grant, the PTAs will push for systems change approaches to enhance family engagement practices through National PTA's updated National Standards for Family-School Partnerships.